Optic nerve sheath meningiomas harbor distinct genetic variants
- 5 January 2026
- journal article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 165 (2)
Abstract
Objective: Both primary optic nerve sheath meningiomas (pONSMs) and secondary optic nerve sheath meningiomas (sONSMs) pose clinical challenges because standard treatments such as surgical debulking and radiation therapy can further damage the optic nerve, producing permanent visual loss. The molecular pathology of primary skull base meningiomas is becoming clearer. However, by comparison, pONSMs and sONSMs have not been studied adequately with contemporary high-throughput molecular genetic techniques, which is the primary aim of this study. This is a crucial issue because these tumors may harbor distinct genetic alterations that render them susceptible to targeted therapy, allowing for vision preservation or even visual improvement. Methods: A total of 18 optic nerve sheath meningiomas, of which 11 were pONSMs and 7 were sONSMs, were obtained from 3 different institutions and underwent next-generation sequencing. Results: We found that pONSMs and sONSMs harbor gene variants previously identified in other meningiomas but also distinct alterations in genes implicated in cell signaling, transcriptional regulation, and DNA damage repair. Conclusions: These findings expand our understanding of a relatively understudied specific meningioma with unique therapeutic challenges.Keywords
Funding Information
- National Institutes of Health (P30 CA006973)
This publication has 21 references indexed in Scilit:
- cIMPACT-NOW update 8: Clarifications on molecular risk parameters and recommendations for WHO grading of meningiomasNeuro-Oncology, 2024
- LZTR1 deficiency exerts high metastatic potential by enhancing sensitivity to EMT induction and controlling KLHL12-mediated collagen secretionCell Death & Disease, 2023
- Molecular classification and grading of meningiomaJournal of Neuro-Oncology, 2023
- Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilitiesNature Genetics, 2022
- Mutational patterns and regulatory networks in epigenetic subgroups of meningiomaActa Neuropathologica, 2019
- DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysisThe Lancet Oncology, 2017
- Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutationsNature Genetics, 2013
- Radiation retinopathy after fractionated stereotactic radiotherapy for optic nerve sheath meningioma,Ophthalmology, 2004
- Choroid plexus papilloma and meningioma: coincidental posterior fossa tumorsSurgical Neurology, 2003
- Optic nerve sheath meningiomasOphthalmology, 2003